CONTEXT: Apathy in community-dwelling elderly individuals has been associated with a history of stroke and other cardiovascular disease. OBJECTIVE: To assess the relationship between symptoms of apathy and cardiovascular risk factors or disease (stroke or other) in a large sample of elderly people aged 70 to 78 years without depression or dementia. DESIGN: Cross-sectional data analysis within an ongoing cluster-randomized, open, multicenter trial. SETTING: The Netherlands, general community. PARTICIPANTS: We studied 3534 elderly individuals without dementia who were included in the Prevention of Dementia by Intensive Vascular Care trial. MAIN OUTCOME MEASURES: Symptoms of apathy, assessed with 3 items from the 15-item Geriatric Depression Scale, in participants with few or no depressive symptoms. RESULTS: The median age of participants was 74.3 years. Principal components analysis of the Geriatric Depression Scale confirmed a separate factor for the apathy items (Geriatric Depression Scale-3A). Two or more symptoms of apathy were present in 699 participants (19.9%), of whom 372 (53.2%) were without depressive symptoms (Geriatric Depression Scale-12D score <2). Ordinal regression analysis showed that increasing apathy in the absence of depressive symptoms was associated with a history of stroke (odds ratio, 1.79; 95% CI, 1.38-2.31) and cardiovascular disease other than stroke (1.28; 1.09-1.52). Exploratory analysis among 1889 participants free from stroke and other cardiovascular disease revealed an association between apathy score and the following cardiovascular risk factors: systolic blood pressure (P = .03), body mass index (P = .002), type 2 diabetes mellitus (P = .07), and C-reactive protein (P < .001). CONCLUSIONS: Symptoms indicative of apathy are common in community-dwelling nondemented older people who are free from depression. The independent association of stroke, other cardiovascular disease, and cardiovascular risk factors with symptoms of apathy suggests a causal role of vascular factors.
RCT Entities:
CONTEXT: Apathy in community-dwelling elderly individuals has been associated with a history of stroke and other cardiovascular disease. OBJECTIVE: To assess the relationship between symptoms of apathy and cardiovascular risk factors or disease (stroke or other) in a large sample of elderly people aged 70 to 78 years without depression or dementia. DESIGN: Cross-sectional data analysis within an ongoing cluster-randomized, open, multicenter trial. SETTING: The Netherlands, general community. PARTICIPANTS: We studied 3534 elderly individuals without dementia who were included in the Prevention of Dementia by Intensive Vascular Care trial. MAIN OUTCOME MEASURES: Symptoms of apathy, assessed with 3 items from the 15-item Geriatric Depression Scale, in participants with few or no depressive symptoms. RESULTS: The median age of participants was 74.3 years. Principal components analysis of the Geriatric Depression Scale confirmed a separate factor for the apathy items (Geriatric Depression Scale-3A). Two or more symptoms of apathy were present in 699 participants (19.9%), of whom 372 (53.2%) were without depressive symptoms (Geriatric Depression Scale-12D score <2). Ordinal regression analysis showed that increasing apathy in the absence of depressive symptoms was associated with a history of stroke (odds ratio, 1.79; 95% CI, 1.38-2.31) and cardiovascular disease other than stroke (1.28; 1.09-1.52). Exploratory analysis among 1889 participants free from stroke and other cardiovascular disease revealed an association between apathy score and the following cardiovascular risk factors: systolic blood pressure (P = .03), body mass index (P = .002), type 2 diabetes mellitus (P = .07), and C-reactive protein (P < .001). CONCLUSIONS: Symptoms indicative of apathy are common in community-dwelling nondemented older people who are free from depression. The independent association of stroke, other cardiovascular disease, and cardiovascular risk factors with symptoms of apathy suggests a causal role of vascular factors.
Authors: Sytze P Rensma; Thomas T van Sloten; Jennifer Ding; Sigurdur Sigurdsson; Coen D A Stehouwer; Vilmundur Gudnason; Lenore J Launer Journal: Diabetes Care Date: 2020-06-11 Impact factor: 19.112
Authors: Thomas T van Sloten; Sigurdur Sigurdsson; Mark A van Buchem; Caroline L Phillips; Palmi V Jonsson; Jie Ding; Miranda T Schram; Tamara B Harris; Vilmundur Gudnason; Lenore J Launer Journal: Am J Psychiatry Date: 2015-03-03 Impact factor: 18.112
Authors: Ari L Harris; Jessica Elder; Nicholas D Schiff; Jonathan D Victor; Andrew M Goldfine Journal: Transl Stroke Res Date: 2013-10-19 Impact factor: 6.829
Authors: James R Hall; April R Wiechmann; Leigh A Johnson; Melissa Edwards; Robert C Barber; A Scott Winter; Meharvan Singh; Sid E O'Bryant Journal: J Alzheimers Dis Date: 2013 Impact factor: 4.472
Authors: George S Alexopoulos; Matthew J Hoptman; Genevieve Yuen; Dora Kanellopoulos; Joanna K Seirup; Kelvin O Lim; Faith M Gunning Journal: J Affect Disord Date: 2012-12-20 Impact factor: 4.839
Authors: Thomas T van Sloten; Gary F Mitchell; Sigurdur Sigurdsson; Mark A van Buchem; Palmi V Jonsson; Melissa E Garcia; Tamara B Harris; Ronald M A Henry; Andrew S Levey; Coen D A Stehouwer; Vilmundur Gudnason; Lenore J Launer Journal: J Psychiatry Neurosci Date: 2016-04 Impact factor: 6.186